Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation

International Journal of Molecular Medicine

Volumn 30, Issue 5, 2012, Pages 1075-1080

  Ye, Yaping ^a   Hu, Weihua ^a   Guo, Fengjing ^a   Zhang, Weikai ^a   Wang, Jiang ^a   Chen, Anmin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Biglycan; Bone morphogenetic protein 4; Glycosaminoglycan chains; Osteoblast differentiation

Indexed keywords

ALKALINE PHOSPHATASE; BIGLYCAN; BONE MORPHOGENETIC PROTEIN 4; GLYCOSAMINOGLYCAN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ADENOVIRIDAE; ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, DIFFERENTIATION; BIGLYCAN; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; GLYCOSAMINOGLYCANS; INTEGRIN-BINDING SIALOPROTEIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; PROTEIN BINDING; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SKULL; SMAD PROTEINS;

EID: 84866612474     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1091     Document Type: Article

References (27)

1. Iozzo RV: The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 274: 18843-18846, 1999.
2. Ameye L and Young MF: Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12: 107R-116R, 2002.
3. Roughley PJ and White RJ: Dermatan sulphate proteoglycans of human articular cartilage. The properties of dermatan sulphate proteoglycans I and II. Biochem J 262: 823-827, 1989. (Pubitemid 19225155)
4. Bianco P, Fisher LW, Young MF, Termine JD and Robey PG: Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38: 1549-1563, 1990. (Pubitemid 20346965)
5. Young MF, Bi Y, Ameye L and Chen XD: Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 19: 257-262, 2002. (Pubitemid 37174553)
6. Xu T, Bianco P, Fisher LW, et al: Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20: 78-82, 1998. (Pubitemid 28410350)
7. Chen XD, Shi S, Xu T, Robey PG and Young MF: Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res 17: 331-340, 2002. (Pubitemid 34087666)
8. Chen XD, Fisher LW, Robey PG and Young MF: The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J 18: 948-958, 2004. (Pubitemid 38787591)
9. Moreno M, Munoz R, Aroca F, Labarca M, Brandan E and Larrain J: Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. EMBO J 24: 1397-1405, 2005. (Pubitemid 40593060)
10. Bernfield M, Gotte M, Park PW, et al: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777, 1999. (Pubitemid 29449208)
11. Casu B and Lindahl U: Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 57: 159-206, 2001. (Pubitemid 34121000)
12. Seidler DG and Dreier R: Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function? IUBMB Life 60: 729-733, 2008.
13. Timmer NM, Kuiperij HB, de Waal RM and Verbeek MM: Do amyloid beta-associated factors co-deposit with Abeta in mouse models for Alzheimer's disease? J Alzheimers Dis 22: 345-355, 2010.
14. Scott JE: Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J 6: 2639-2645, 1992.
15. Nikitovic D, Zafiropoulos A, Tzanakakis GN, Karamanos NK and Tsatsakis AM: Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions. Anticancer Res 25: 2851-2856, 2005. (Pubitemid 41044672)
16. Bouvier M, Couble ML, Hartmann DJ, Gauthier JP and Magloire H: Ultrastructural and immunocytochemical study of bone-derived cells cultured in three-dimensional matrices: influence of chondroitin-4 sulfate on mineralization. Differentiation 45: 128-137, 1990.
17. Chen XD, Qian HY, Neff L, Satomura K and Horowitz MC: Thy-1 antigen expression by cells in the osteoblast lineage. J Bone Miner Res 14: 362-375, 1999. (Pubitemid 29106713)
18. McCarthy TL, Centrella M and Canalis E: Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 3: 401-408, 1988.
19. Komori T, Yagi H and Nomura S, et al: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764, 1997. (Pubitemid 27516178)
20. Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G: Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754, 1997. (Pubitemid 27516177)
21. Karsenty G: The genetic transformation of bone biology. Genes Dev 13: 3037-3051, 1999.
22. Parisuthiman D, Mochida Y, Duarte WR and Yamauchi M: Biglycan modulates osteoblast differentiation and matrix mineralization. J Bone Miner Res 20: 1878-1886, 2005. (Pubitemid 41361890)
23. Miyazaki T, Miyauchi S, Tawada A, Anada T, Matsuzaka S and Suzuki O: Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. J Cell Physiol 217: 769-777, 2008.
24. Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J and Kresse H: Interaction of biglycan with type I collagen. J Biol Chem 270: 2776-2783, 1995.
25. Miguez PA, Terajima M, Nagaoka H, Mochida Y and Yamauchi M: Role of glycosaminoglycans of biglycan in BMP-2 signaling. Biochem Biophys Res Commun 405: 262-266, 2011.
26. Wang X, Harimoto K, Xie S, Cheng H, Liu J and Wang Z: Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways. Biol Pharm Bull 33: 1891-1897, 2010.
27. Roughley PJ, White RJ, Magny MC, Liu J, Pearce RH and Mort JS: Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J 295: 421-426, 1993. (Pubitemid 23315180)